Akt1-and-Akt2-IN-1 - Akt 抑制劑 - 生命科學(xué)試劑 - MedChemExpress

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEAkt1 and Akt2-IN-1Cat. No.: HY-50862CAS No.: 893422-47-4分式: CHNO分量: 539.63作靶點(diǎn): Akt作通路: PI3K/Akt/mTOR儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 35 mg/mL (64.86 mM)* means soluble, but s

2、aturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 1.8531 mL 9.2656 mL 18.5312 mL5 mM 0.3706 mL 1.8531 mL 3.7062 mL10 mM 0.1853 mL 0.9266 mL 1.8531 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度，選擇合適的溶劑配制儲(chǔ)備液，并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Akt1 and Akt2-IN-1種有效的變構(gòu)抑制劑, 抑制 Akt1 (IC50=3.5 nM) 和 Akt2 (IC50=4

3、2 nM)。IC50 & Target Akt1 Akt23.5 nM (IC50) 42 nM (IC50)體外研究Consistent with the allosteric mode of inhibition, Akt1 and Akt2-IN-1 (Compound 17) is dependent on the PH-1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemEdomain for Akt inhibition, is selective for Akt1/2 over Akt3 (IC50=1900 nM), and is h

4、ighly selective over othermembers of the AGC family of kinases (50 M vs PKA, PKC, SGK). Akt1 and Akt2-IN-1 (Compound 17) hasmoderate activity in an hERG binding assay (IC50=5610 nM) and is a substrate for human P-glycoprotein 1.體內(nèi)研究 Akt1 and Akt2-IN-1 (Compound 17) is well tolerated in at exposures

5、that provide high levels of Akt1 and 2inhibition in vivo. Akt1 and Akt2-IN-1 (Compound 17) has also been shown to inhibit the growth of A2780tumors in vivo when used as monotherapy. Akt1 and Akt2-IN-1 (Compound 17) has potent inhibitory activityagainst Akt1 and 2 in vivo in a mouse lung and efficacy

6、 in a tumor xenograft model. Akt1 and Akt2-IN-1(Compound 17) shows good pharmacokinetics in rat with a low clearance of 4.6 mL/min/kg and a half-life of3.8 h. Due to the improved cell potency, physical properties, and rodent pharmacokinetics of Akt1 and Akt2-IN-1 (Compound 17), tolerability and Akt

7、inhibition are assessed in mice. Using an acute dosing schedule (IPdosing of 50 mg/kg at times 0, 3, and 8 h), administration of Akt1 and Akt2-IN-1 (Compound 17) is welltolerated in mice and shows high levels of Akt inhibition in mouse lung 1.REFERENCES1. Bilodeau MT, Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model. Bioorg MedChem Lett. 2008 Jun 1;18(11):3178-82.McePdfHeightCaution: Product has not been fully validated for medical applications.For rese